| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 885 | 2021 |
| Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension A Boucly, J Weatherald, L Savale, X Jaïs, V Cottin, G Prevot, F Picard, ... European Respiratory Journal 50 (2), 2017 | 673 | 2017 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 276 | 2021 |
| French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension P Brenot, X Jaïs, Y Taniguchi, CG Alonso, B Gerardin, S Mussot, ... European Respiratory Journal 53 (5), 2019 | 210 | 2019 |
| Prognostic value of follow-up hemodynamic variables after initial management in pulmonary arterial hypertension J Weatherald, A Boucly, D Chemla, L Savale, M Peng, M Jevnikar, X Jaïs, ... Circulation 137 (7), 693-704, 2018 | 174 | 2018 |
| Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation A Beurnier, EM Jutant, M Jevnikar, A Boucly, J Pichon, M Preda, M Frank, ... European Respiratory Journal 56 (5), 2020 | 126 | 2020 |
| Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension A Boucly, L Savale, X Jaïs, F Bauer, E Bergot, L Bertoletti, A Beurnier, ... American journal of respiratory and critical care medicine 204 (7), 842-854, 2021 | 112 | 2021 |
| External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry A Boucly, J Weatherald, L Savale, P De Groote, V Cottin, G Prévot, ... European Respiratory Journal 59 (6), 2022 | 108 | 2022 |
| Portopulmonary hypertension in the current era of pulmonary hypertension management L Savale, M Guimas, N Ebstein, M Fertin, M Jevnikar, S Renard, ... Journal of Hepatology 73 (1), 130-139, 2020 | 107 | 2020 |
| Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label … X Jaïs, P Brenot, H Bouvaist, M Jevnikar, M Canuet, C Chabanne, ... The Lancet Respiratory Medicine 10 (10), 961-971, 2022 | 98 | 2022 |
| Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension J Weatherald, A Boucly, D Launay, V Cottin, G Prévot, D Bourlier, ... European Respiratory Journal 52 (4), 2018 | 87 | 2018 |
| Screening for pulmonary arterial hypertension in systemic sclerosis J Weatherald, D Montani, M Jevnikar, X Jaïs, L Savale, M Humbert European Respiratory Review 28 (153), 2019 | 83 | 2019 |
| Acute decompensated pulmonary hypertension L Savale, J Weatherald, X Jaïs, C Vuillard, A Boucly, M Jevnikar, ... European Respiratory Review 26 (146), 2017 | 71 | 2017 |
| Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission M Jevnikar, O Sanchez, R Chocron, M Andronikof, M Raphael, ... European Respiratory Journal 58 (1), 2021 | 67 | 2021 |
| Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension YU Taniguchi, X Jaïs, M Jevnikar, A Boucly, J Weatherald, P Brenot, ... The Journal of Heart and Lung Transplantation 38 (8), 833-842, 2019 | 67 | 2019 |
| Association between BMI and obesity with survival in pulmonary arterial hypertension J Weatherald, A Huertas, A Boucly, C Guignabert, Y Taniguchi, Y Adir, ... Chest 154 (4), 872-881, 2018 | 60 | 2018 |
| Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension L Godinas, C Sattler, EM Lau, X Jaïs, Y Taniguchi, M Jevnikar, ... The Journal of Heart and Lung Transplantation 36 (11), 1234-1242, 2017 | 42 | 2017 |
| Opening of a respiratory intermediate care unit in a general hospital: impact on mortality and other outcomes M Confalonieri, R Trevisan, M Demsar, L Lattuada, C Longo, R Cifaldi, ... Respiration 90 (3), 235-242, 2015 | 40 | 2015 |
| Factors predicting outcome after pulmonary endarterectomy C Tromeur, X Jaïs, O Mercier, F Couturaud, D Montani, L Savale, ... PloS one 13 (6), e0198198, 2018 | 38 | 2018 |
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 36 | 2022 |
